This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Willerson, J. T. Articles by Stokley, E. M. Search for Related Content PubMed PubMed Citation Articles by Willerson, J. T. Articles by Stokley, E. M.

Circulation, Vol 51, 1046-1052, Copyright © 1975 by American Heart Association

ARTICLES

Technetium stannous pyrophosphate myocardial scintigrams in patients with chest pain of varying etiology

JT Willerson, RW Parkey, FJ Bonte, SL Meyer, JM Atkins and EM Stokley

Technetium-99m stannous pyrophosphate was utilized for myocardial imaging in 202 patients admitted to the hospital with chest pain of uncertain etiology. One hundred and one patients had clinical and evolved electrocardiographic and enzymatic evidence of acute myocardial infarction. Ninety-six of these 101 patients had increased myocardial uptake of the technetium stannous pyrophosphate and positive myocardial scintigrams; there was nearly precise correlation between the ECG and myocardial imaging localization of the area of infarction for acute transmural myocardial infarctions. In the five patients with negative myocardial images the scintigrams were obtained after seven or more days had elapsed following the myocardial infarction. In the remaining 101 patients no clinical, ECG, or enzymatic evidence of infarction developed; 92 of these patients had negative myocardial scintigrams. Seven of the remaining nine patients were admitted with "unstable angina pectoris", and despite the absence of diagnostic ECG and enzyme evolution each of these patients had faintly and diffusely positive myocardial scintigrams. The remaining two patients had positive myocardial scintigrams but no definite ECG or enzymatic evidence of acute myocardial infarction. Thus the technetium pyrophosphate imaging technique appears safe, inexpensive and to correlate well with ECG and enzyme identification of the presence of infarction and with ECG localization of myocardial infarction. In addition the positive myocardial scintigrams in some patients with "unstable angina" suggest that there may be limited myocardial necrosis that is ordinarily undetected by ECG and enzymes in these patients. The incidence of false positive and false negative scintigrams appears to be small.

This article has been cited by other articles:

				V. Pasceri and E. T. H. Yeh A Tale of Two Diseases : Atherosclerosis and Rheumatoid Arthritis Circulation, November 23, 1999; 100(21): 2124 - 2126. [Full Text] [PDF]

				J. Narula, A. Petrov, K.-Y. Pak, B. C. Lister, and B.-A. Khaw Very Early Noninvasive Detection of Acute Experimental Nonreperfused Myocardial Infarction With 99mTc-Labeled Glucarate Circulation, March 18, 1997; 95(6): 1577 - 1584. [Abstract] [Full Text]

				B. Pitt Risk Stratification in Patients With Unstable Angina : `Deja Vu All Over Again'? Circulation, May 1, 1996; 93(9): 1618 - 1620. [Full Text]

				M Lewis, L. Buja, S Saffer, D Mishelevich, E Stokely, S Lewis, R Parkey, F Bonte, and J Willerson Experimental infarct sizing using computer processing and a three-dimensional model Science, July 8, 1977; 197(4299): 167 - 169. [Abstract] [PDF]